MADELEINE PRICE: Open Payments
NPI 1124750690 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 48 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,106 · 2025 $1,163
Food & beverage: $1,129Education: $34
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $345 |
| Novartis Pharmaceuticals Corporation | 5 | $118 |
| CSL Behring | 4 | $87 |
| Grifols USA, LLC | 3 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| Octapharma USA, Inc. | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| BioCryst US Sales Co., LLC | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Amgen Inc. | 2 | $53 |
Products named: DUPIXENT, Hizentra, ORLADEYO, Prolastin-C Liquid, TEZSPIRE, Xolair, NEFFY, CUTAQUIG.
Industry payments across GA — which companies pay providers there.
